An EPA health advisory for two prominent “forever chemicals” is fit to be challenged in federal court after the agency said the advisory is immune to judicial review, Chemours argued in a legal brief.
The company on Wednesday asked the court to deny EPA’s motion to dismiss.
In its motion, the EPA said its June health advisory “does not impose any burdens on Chemours,” which manufactures ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
